about
Management of low (favourable)-risk prostate cancerAdvances in understanding the peptide neurotransmitter NAAG and appearance of a new member of the NAAG neuropeptide familyHigh-throughput screen identifies novel inhibitors of cancer biomarker α-methylacyl coenzyme A racemase (AMACR/P504S)The evolution of imaging in cancer: current state and future challenges.Glutamate carboxypeptidase II in diagnosis and treatment of neurologic disorders and prostate cancerImaging in prostate cancer staging: present role and future perspectives.Near-infrared fluorescence and nuclear imaging and targeting of prostate cancer.Intravital imaging of human prostate cancer using viral nanoparticles targeted to gastrin-releasing Peptide receptors.The Mind: Focal Cryotherapy in Low-Risk Prostate Cancer: Are We Treating the Cancer or the Mind?Novel Imaging of Prostate Cancer with MRI, MRI/US, and PET.New prospects for PET in prostate cancer imaging: a physicist's viewpoint.NMR-based metabolomics of prostate cancer: a protagonist in clinical diagnostics.PET imaging of prostate tumors with 18F-Al-NOTA-MATBBN.Pilot study of a novel (18)F-labeled FSHR probe for tumor imaging.2-(3-{1-Carboxy-5-[(6-[18F]fluoro-pyridine-3-carbonyl)-amino]-pentyl}-ureido)-pentanedioic acid, [18F]DCFPyL, a PSMA-based PET imaging agent for prostate cancer.An affinity matured minibody for PET imaging of prostate stem cell antigen (PSCA)-expressing tumors.A dimerized urea-based inhibitor of the prostate-specific membrane antigen for 68Ga-PET imaging of prostate cancer.Novel Preclinical and Radiopharmaceutical Aspects of [68Ga]Ga-PSMA-HBED-CC: A New PET Tracer for Imaging of Prostate CancerEarly dynamic imaging in 68Ga- PSMA-11 PET/CT allows discrimination of urinary bladder activity and prostate cancer lesions.
P2860
Q26996501-86DD1683-2B35-4DED-8117-1C32D4760C18Q30465259-9CBF3DAD-04DD-4C00-A3B4-72A564A0D279Q36176367-C4FF9EC3-E4BF-4F22-93DF-651296C4FE59Q37848518-701CDBFB-16A5-4BCE-9535-63D8C09A126EQ37972920-F9F5118F-5F70-404E-B5BD-D6DCFFC4809FQ37979650-EA1A9870-B274-441C-81A3-7FA5EAA73EB2Q38256977-0D7FC506-23CA-4381-AE47-99B1033B333FQ38269032-C7248083-AB39-42F3-ACC7-C330FE3B1B9FQ38391339-B0359058-4246-4BB0-8503-A4BF636C301BQ38606252-39065835-EDA1-4D1C-B446-CBDE297EA72FQ38616392-DC31A011-AC2F-48EC-878E-FAEE407A276DQ38767020-77A036A0-3E11-453E-9362-7A624F045483Q39004440-8AF7BCA7-8A70-441E-B4B6-F63EDCA240D1Q39037392-044B422E-34F9-42D9-994C-FAC189BD4F67Q39449818-95DCA53E-B936-447E-9550-02423DE1ECE7Q39720680-1DB11137-A42C-4168-B90D-D1DEBDB5D91AQ41600550-1D83A7B4-CE11-4621-A0B0-2D8765EC5CB1Q41905456-D953E4D3-82B0-4B90-B3C3-3E40EF32B14FQ48189196-36BB9320-831A-49A6-B81E-9B0FAC6CD57B
P2860
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
2009年论文
@zh
2009年论文
@zh-cn
name
New agents and techniques for imaging prostate cancer.
@ast
New agents and techniques for imaging prostate cancer.
@en
type
label
New agents and techniques for imaging prostate cancer.
@ast
New agents and techniques for imaging prostate cancer.
@en
prefLabel
New agents and techniques for imaging prostate cancer.
@ast
New agents and techniques for imaging prostate cancer.
@en
P2093
P2860
P1476
New agents and techniques for imaging prostate cancer.
@en
P2093
Atif Zaheer
Martin G Pomper
Steve Y Cho
P2860
P304
P356
10.2967/JNUMED.109.061838
P407
P577
2009-08-18T00:00:00Z